2nd Vaccine World Japan 2021

Japan's vaccine market is currently valued at $190 billion, accounting for more than 3% of the whole pharmaceutical market. Especially after the Covid-19 pandemic, local governments raised initiatives to increase vaccine development and it is likely to further boost growth of the Japan vaccines market.

Vaccines World Japan 2021 aims to provide a neutral learning and networking platform to navigate the challenges faced in this industry including: R&D, Process Development & Manufacturing of Vaccines including Cancer Vaccines | Handling Pandemic Threats in Japan market | Preparing for Vaccine Launches | Clinical Trials Infrastructure Challenges | Clinical Trials in Local and Global Immunotherapy Vaccines | Case Studies on Diseases such as HIV, Malaria, Dengue, Influenza, Tuberculosis, HPV | Immunization & Coverage | Vaccine Pricing & Surveillance: IP Challenges and Cost-Effectiveness of Vaccines | Complexities in Adjuvants, Delivery Systems | Global Logistical Challenges during Various Phases of Clinical Trials | Updates of Pipelines and Clinical Trial Results on Infectious Disease.